David Lebwohl, EVP, Chief Medical Officer: Intellia Therapeutics NTLA Sell · Filed 23/01/06

Trade details

Type: Insider sale
Amount: $95,778.54
Shares · price: 2,574 sh · $37.21 a share
Held after: 25,687 sh
Stock: Intellia Therapeutics NTLA
Person: David LebwohlEVP, Chief Medical Officer
Trade date: 23/01/04
Filed: 23/01/06
Days to filing: 2 days

Sold 9.1% of holdings

Share of holding sold: 9.1%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/05~23/02/03

David Lebwohl's recent trades

David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$109.6K
11,903 sh
$109.6K
Filed 01/07
Traded 01/05
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$116.4K
9,557 sh
$116.4K
Filed 25/01/07
Traded 25/01/03
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$172.1K
5,843 sh
$172.1K
Filed 24/01/05
Traded 24/01/03